Entellus engages in delivering minimally invasive ENT procedures for the treatment of adult and pediatric patients with chronic and recurrent sinusitis.
Business Model:
Revenue: $86.2M
Employees: 201-500
Entellus Medical was acquired by
Stryker.
The acquisition happend on 2017-12-07.
Details of the transaction were not public
Address: 3600 Holly Ln N
City: Plymouth
State: MN
Zip: 55447
Country: US
Entellus engages in delivering minimally invasive ENT procedures for the treatment of adult and pediatric patients with chronic and recurrent sinusitis.
Contact Phone:
+17634631595
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/6/2015
Ticker Symbol:
ENTL
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
7/2017 | Spirox | |
9/2013 | CogENT Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|